“DRG has integrated quality service with imaging data technology, which exactly fits into the M2S mission and http://m2s.com/content/clinical-trials-imaging [clinical trials image management service] offering. The addition of DRG allows M2S to further expand our capabilities and therapeutic expertise, and meet the growing demand for image management services worldwide,” M2S CEO Wes Chapman said.
“Adding M2S high-speed image collection and trial management technologies to DRG’s proprietary quality system and data management, enables us to greatly increase our presence in the drug development market,” said Reta Rupich, President of DXA Resource Group.
About M2S, Inc. M2S provides image and data management services for clinical trials sponsors in the biopharmaceutical and medical device industries, http://m2s.com/content/data-registries [patient registry databases] and is a recognized leader in 3-D endovascular treatment planning. For the past 10 years, M2S has managed, under protocol, millions of images from around the globe in various therapeutic areas and in all DICOM modalities.
For more information, visit www.m2s.com. About DXA Resource Group DXA Resource group is a clinical trials service company focused on providing customer-centric, cost-effective quality assurance as well as data and project management for clinical trials involving Dual X-ray Absorptiometry (DXA) measurements. For more information visit www.dxaresourcegroup.com or www.m2s.com.
